Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by Heather Sieben Bell, Josh Solem, Heather Sieben Bell, and Josh Solem. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Heather Sieben Bell, Josh Solem, Heather Sieben Bell, and Josh Solem or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

77. MOUD- Buprenorphine (Suboxone-Subutex-Sublocade) 101

1:03:59
 
Share
 

Manage episode 445809080 series 3478771
Content provided by Heather Sieben Bell, Josh Solem, Heather Sieben Bell, and Josh Solem. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Heather Sieben Bell, Josh Solem, Heather Sieben Bell, and Josh Solem or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

On the last MOUD episode, we discussed Methadone (a full agonist opioid treatment for OUD) and Naltrexone (an antagonist treatment for OUD). In this episode, we will discuss Buprenorphine, which is a partial agonist opioid treatment for OUD. Buprenorphine, the sublingual name brands of Suboxone and Subutex and the injectable name brand of Sublocade, is becoming a mainstay of treatment for OUD. We will discuss the hows and whys of buprenorphine and what makes it a great treatment option.

For questions, comments, episode recommendations or requests or to learn more, email us at: [email protected]
Twitter: @A2RPodcast
Facebook: Addiction2Recovery Podcast
Instagram: Addiction2RecoveryPodcast

  continue reading

85 episodes

Artwork
iconShare
 
Manage episode 445809080 series 3478771
Content provided by Heather Sieben Bell, Josh Solem, Heather Sieben Bell, and Josh Solem. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Heather Sieben Bell, Josh Solem, Heather Sieben Bell, and Josh Solem or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

On the last MOUD episode, we discussed Methadone (a full agonist opioid treatment for OUD) and Naltrexone (an antagonist treatment for OUD). In this episode, we will discuss Buprenorphine, which is a partial agonist opioid treatment for OUD. Buprenorphine, the sublingual name brands of Suboxone and Subutex and the injectable name brand of Sublocade, is becoming a mainstay of treatment for OUD. We will discuss the hows and whys of buprenorphine and what makes it a great treatment option.

For questions, comments, episode recommendations or requests or to learn more, email us at: [email protected]
Twitter: @A2RPodcast
Facebook: Addiction2Recovery Podcast
Instagram: Addiction2RecoveryPodcast

  continue reading

85 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Listen to this show while you explore
Play